BACKGROUND Human papillomavirus (HPV) is one of the most common sexually transmitted causes of infections and adolescents are at high risk. The aim of the study was to evaluate university students' HPV knowledge before and after educational intervention on HPV. METHODS This study was undertaken in the Celal Bayar University, Manisa, Turkey. A total of 553 university students were educated abo...

Background: Cervical cancer is the fourth leading cause of cancer death in women worldwide. Persistent infection with a high risk human papillomavirus (HR-HPV) is the main etiological factor, so that early early detection of HR-HPV is very important. The aim of this study was to investigate the efficacy of CareTM HPV, a new method, as compared with Pap smear, PCR, and biopsy for screening purpo...

In the Norwegian Cervical Cancer Screening Programme tests for detection of human papillomavirus (HPV) are used to triage women with minor cytological cervical lesions. The material in this study comprises samples from 1 798 women in the period 2006-08. The HPV test was performed according to the guidelines of the Norwegian Cancer Registry. The HPV mRNA test (PreTect HPV-Proofer) detects and ty...

This study demonstrates that both the clinical sensitivity and specificity of the Cervista HPV HR test for high-risk human papillomavirus (HPV) detection are not inferior to those of the Hybrid Capture 2 (HC2) test. The intra- and interlaboratory reproducibilities of Cervista were 92.0% (kappa, 0.83) and 90.4% (kappa, 0.80), respectively. The Cervista HPV HR test fulfills all the international ...

This study evaluated the clinical performance of the cobas 4800 HPV Test (Roche Molecular Systems, Pleasanton, CA) for high-risk human papillomavirus (HR-HPV) testing with individual HPV-16/HPV-18 genotyping in women 21 years or older with atypical squamous cells of undetermined significance (ASC-US). Women (N = 47,208) were recruited in the United States during routine screening, and liquid-ba...

page 2, line 12, «screening with cervical cytology (old policy)» => «screening with cervical cytology with HPV-test in triage of ASC-US / LSIL (old policy)» Abstract, page 2, line 12-14, «screening with HPV testing, followed by triage with cytology (new policy)» => screening with HPV-test with cytology in triage of HPV positive (new policy)» page 2, line 12-14, «screening with HPV testing, foll...

Background: Human Papilloma viruses (HPV) is the most common sexually transmitted infection (STI) and the most important pathogenic factor for cervical intraepithelial lesions and carcinoma therefore a significant source of morbidity and mortality worldwide. This study was designed to investigate reproductive and medical factors associated with HPV infection in women referred to Colposcopy clin...

OBJECTIVE To investigate the incidence of high-risk human papillomavirus (HPV) infection and its clinical meaning. METHODS Total 28,339 women attending our hospital for routine gynecologic care underwent Papanicolaou test (PAP test) and high-risk HPV tests. Biopsies were taken from some women and their results were compared. RESULTS The prevalence of high-risk HPV infection is 24.15%. And t...

BACKGROUND Guidelines recommend screening for cervical cancer among women 30 years or older 3 years after a normal Papanicolaou test (hereinafter referred to as Pap test) result or a combined normal screening result (normal Pap/negative human papillomavirus [HPV] test results). We assessed reported recommendations by US primary care physicians (PCPs) on screening intervals that incorporate HPV ...